-
Finance and Audit Committee
Search
| (ENZN) NASDAQ | |||
| Last Trade | 10.31 | ||
| Change(%) |  | +0.46 | |
| Volume | 1303491 | ||
| 8:10 PM - Mar 10, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
04-29-2009
Enzon to Release First Quarter...
Enzon to Release First Quarter 2009 Earnings on Thursday, May 7, 2009; Conference Call and Webcast to Follow
-
02-10-2009
Enzon Announces IND Acceptance...
Enzon Announces IND Acceptance for its Survivin Antagonist
-- Phase I study to open for patients with solid tumors-- -
05-28-2008
Jack Geltosky, Ph.D. Joins Enz...
Jack Geltosky, Ph.D. Joins Enzon's Board of Directors
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
04-30-2008
Enzon to Release First Quarter...
Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008; Conference Call and Webcast to Follow
-
03-17-2008
Enzon's PEG-SN38 Featured in C...
Enzon's PEG-SN38 Featured in Clinical Cancer Research
-
10-30-2007
Enzon Initiates Second Phase 1...
Enzon Initiates Second Phase 1 Study of Its HIF-1 Alpha Antagonist